Non-COVID-19 UK clinical trials and the COVID-19 pandemic: impact, challenges and possible solutions
Description
CONCLUSION: We have highlighted wide-ranging, extensive and consistent pandemic-related challenges faced by UK clinical trials, which the QRI helped to identify and, in some cases, address. Many challenges were insurmountable at individual trials or
